4.8 Article

Epstein-Barr virus latency programs dynamically sensitize B cells to ferroptosis

出版社

NATL ACAD SCIENCES
DOI: 10.1073/pnas.2118300119

关键词

lipid metabolism; tumor virus; ferroptosis; oxidative stress; B lymphocyte

资金

  1. NIH [RO1 AI137337, AI164709, CA228700]
  2. Burroughs Wellcome Career Award in Medical Sciences
  3. Maximizing Access to Research Careers (MARC) Undergraduate Student Training in Academic Research (U*STAR) program at the University of Rhode Island, Howlett, Niall G. [T34GM131948]
  4. Harvard Summer Honors Undergraduate Research Program (SHURP)
  5. [T32AI007245]

向作者/读者索取更多资源

Epstein-Barr virus (EBV) infection plays a role in multiple cancers, and this study examines how EBV infection affects sensitivity to ferroptosis, a form of cell death driven by lipid peroxidation and membrane damage. The study finds that EBV-infected B cells are sensitive to blockage of glutathione biosynthesis and have elevated levels of lipid reactive oxygen species (ROS) that require SLC7A11 and GPX4 activity to prevent ferroptosis. Different stimulation methods affect the sensitivity of B cells to ferroptosis, and EBV-transformed B cells become progressively resistant to ferroptosis induction.
Epstein-Barr virus (EBV) causes 200,000 cancers annually. Upon B cell infection, EBV induces lipid metabolism to support B cell proliferation. Yet, little is known about how latent EBV infection, or human B cell stimulation more generally, alter sensitivity to ferroptosis, a nonapoptotic form of programmed cell death driven by iron-dependent lipid peroxidation and membrane damage. To gain insights, we analyzed lipid reactive oxygen species (ROS) levels and ferroptosis vulnerability in primary human CD19+ B cells infected by EBV or stimulated by key B cell receptors. Prior to the first mitosis, EBV-infected cells were exquisitely sensitive to blockade of glutathione biosynthesis, a phenomenon not observed with B cell receptor stimulation. Subsequently, EBV-mediated Burkitt-like hyperproliferation generated elevated levels of lipid ROS, which necessitated SLC7A11-mediated cystine import and glutathione peroxidase 4 (GPX4) activity to prevent ferroptosis. By comparison, B cells were sensitized to ferroptosis induction by combinatorial CD40-ligand and interleukin-4 stimulation or anti-B cell receptor and Toll-like receptor 9 stimulation upon GPX4 inhibition but not with SLC7A11 blockade. EBV transforming B cells became progressively resistant to ferroptosis induction upon switching to the latency III program and lymphoblastoid physiology. Similarly, latency I Burkitt cells were particularly vulnerable to blockade of SLC7A11 or GPX4 or cystine withdrawal, while latency III Burkitt and lymphoblastoid cells were comparatively resistant. The selenocysteine biosynthesis kinase PSTK was newly implicated as a cellular target for ferroptosis induction including in Burkitt cells, likely due to roles in GPX4 biosynthesis. These results highlight ferroptosis as an intriguing therapeutic target for the prevention or treatment of particular EBV-driven B cell malignancies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据